User:Eirini Trompouki

Peer-reviewed Publications 1. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. “CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.” Nature. 2003 Aug 14;424(6950):738-9. 2. Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK, Mosialos G, Li JD. “NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.” J Biol Chem. 2004 Aug27;279(35):36171-4. 3. Trompouki E, Tsagaratou A, Kosmidis SK, Dollé P, Qian J, Kontoyiannis DL, Cardoso WV, Mosialos G. “ Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation.” Neoplasia. 2009 May;11(5):469-76. 4. Tsagaratou A, Trompouki E, Grammenoudi S, Kontoyiannis DL, Mosialos G. “Thymocyte-Specific Truncation of the Deubiquitinating Domain of CYLD Impairs Positive Selection in a NF-{kappa}B Essential Modulator-Dependent Manner.” J. Immunol. 2010 Aug 15;185(4):2032-43. Epub 2010 Jul 19. 5. ►Trompouki E. *, Bowman TV*, Lawton L.N., Peng Fan Z., Wu D.C., DiBiase A., Martin C.S., Cech J.N.,. Sessa A. K., Leblanc J.L, Li P., Durand E.M., Mosimann C., Heffner G.C., Daley G.Q., Paulson R.F., Young R.A. and Zon L.I. “Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration”, *equal contribution. Cell. 2011 Oct 28;147(3):577-89.